ROBINS CHAD M

PrivateCIK: 1780649
Location

SEATTLE, WA

ROBINS CHAD M (CEO and Chairman) sold 21.6% of their position (600K shares) of ADAPTIVE BIOTECHNOLOGIES CORP on the open market

Open‑market sale worth $14.88M — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.

S · 4 sales
InsiderROBINS CHAD MCIK 1780649
DirectorOfficer· CEO and Chairman
Since Jun 2019
-600K
Net shares
Net seller
$14.88M
Total sold
4
Open market trades
0B · 4S
8
Total transactions
600K acquired · 1.20M disposed
Non-Derivative Transactions6

Common Stock

Direct
M · Option Exercise

Shares

+321.32K

Price / share

$6.55

Trade value

$2.10M

% of position

14.7%
8/17/2026
2.18M2.50M

Common Stock

Direct
S · Sale

Shares

318.80K

Price / share

$25.08

Trade value

$8M

% of position

12.7%
8/17/2026
2.50M2.18M

Common Stock

Direct
S · Sale

Shares

2.52K

Price / share

$25.57

Trade value

$64.56K

% of position

0.1%
8/17/2026
2.18M2.18M

Common Stock

Direct
M · Option Exercise

Shares

+278.68K

Price / share

$6.55

Trade value

$1.83M

% of position

12.8%
8/18/2026
2.18M2.46M

Common Stock

Direct
S · Sale

Shares

278.47K

Price / share

$24.48

Trade value

$6.82M

% of position

11.3%
8/18/2026
2.46M2.18M

Common Stock

Direct
S · Sale

Shares

204.00

Price / share

$25.14

Trade value

$5.13K

% of position

0.0%
8/18/2026
2.18M2.18M
Total

Net shares

+0.00

Net value

-$10.95M

Derivative Transactions2

Stock Option (right to buy)

Direct
M · Option Exercise
Converts to

Common Stock

321.32K shares

Shares

321.32K

Strike price

6.55

Held after

278.68K

Exercisable

8/17/2026

Stock Option (right to buy)

Direct
M · Option Exercise
Converts to

Common Stock

278.68K shares

Shares

278.68K

Strike price

6.55

Held after

0.00

Exercisable

8/18/2026